Open AccessThe clinical efficacy of using autologous platelet rich plasma in hip arthroplasty: A retrospective comparative study
Author(s) -
Atif Safdar,
Hamid Shaaban,
Restituto Tibayan,
Richard A. Miller,
Richard Boairdo,
Gunwant Guron
Publication year - 2015
Publication title -
journal of natural science, biology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 30
eISSN - 2229-7707
pISSN - 0976-9668
DOI - 10.4103/0976-9668.149077
Subject(s) - medicine , perioperative , surgery , platelet rich plasma , blood transfusion , retrospective cohort study , arthroplasty , analgesic , anesthesia , hip replacement , platelet
Platelet rich plasma (PRP) is a blood derivative concentrate of platelets, fibrin and growth factors obtained through withdrawal and centrifugation of autologous blood and use for its inherent hemostatic and adhesive properties to promote wound healing. Hip arthroplasty is often associated with significant perioperative complications including blood loss necessitating blood transfusions, which can lead to multiple adverse reactions, infection transmission, and longer hospital stay.